| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |